the hyperfibrinogenemia is associated with the prolongation of dilute blood clot lysis times , appearance of heparin-precipitable fibrinogen , elevations in fibrin degradation products , and complement titers and serum electrophoretic pattern changes that consist of decreased albumin concentrations and increased beta globulin concentrations .
C0009498
complement
C0229671
serum